GSD:CC News and Press, Devonian Health Group Inc. From 02/26/24

GSD:CC - Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...

GSD:CC - Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD:CC - Devonian Bolsters Intellectual Property With Issuance of U.S. Patent Covering a Method of Treatment of Inflammatory Bowel Disease

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced ...

GSD:CC - Devonian Seeks Shareholders Approval for Share Consolidation

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...

GSD:CC - Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive Revenue Growth and Commercial Success

Luc Grégoire, current Director of Devonian, appointed as President and CEO, brings 30 years of financial capital markets, strategic and operational leadership David Baker transitions from board director with appointment as non-executive Chairman of the Board of Directors ...

GSD:CC - Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine(TM) in Wound Healing

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...

GSD:CC - Devonian Announces Closing of a Private Placement of $500,000

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, ...

GSD:CC - Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB : DVHGF ), a clinical late stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, , is ...

GSD:CC - Devonian Announces Closing of a Private Placement of $1.2 Million

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD:CC - Devonian Announces Private Placement of up to $5 Million

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

Company Name:	Devonian Health Group Inc.
Stock Symbol:	GSD:CC
Market:	TSXVC
Website:	groupedevonian.com